Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Biocept financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.4
2024-08-19
Market Capitalization
$1.1 M
2023-12-22
Revenue
$25.9 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | 5.1M | 3.3M | 5.5M | 27.5M | 61.2M | 25.9M | |
| Revenue growth, % | -35.9% | ||||||
| Cost of goods sold | 6.9M | 9.3M | 10.1M | 11.0M | 21.3M | 37.8M | 28.4M |
| Gross profit | (4.3M) | (6.8M) | (5.4M) | 6.1M | (2.5M) | ||
| Gross profit margin, % | -84.4% | -209.3% | -98.6% | 22.3% | -9.8% | ||
| General and administrative expense | 6.6M | 7.2M | 7.1M | 7.0M | 10.0M | 12.6M | 16.1M |
| Operating expense total | 21.2M | 26.2M | 27.5M | 17.6M | 21.6M | 25.9M | 29.4M |
| EBIT | (18.0M) | (21.2M) | (24.3M) | (23.1M) | (15.5M) | (2.4M) | (32.0M) |
| EBIT margin, % | -417.8% | -746.4% | -417.1% | -56.3% | -123.5% | ||
| Interest expense | 525.9K | 482.6K | 311.0K | 316.0K | |||
| Pre tax profit | (18.4M) | (21.6M) | (24.6M) | (25.1M) | (17.8M) | (2.7M) | (32.2M) |
| Income tax expense | 2.1K | 7.6K | (1.9K) | 125.0K | (125.0K) | ||
| Net Income | (18.4M) | (21.6M) | (25.2M) | (25.1M) | (17.8M) | (2.8M) | (32.1M) |
| EPS | (1.9) |